When we talk to diabetes experts they all say that GLP-1 agonists will continue to change the way we treat diabetes now and in the future. They also comment on the slow but growing acceptance of this class as the "go to" drug for type 2 diabetes. In last month’s …
Read More »Diabetes In Control
Letter from the Editor #717: Mobile Healthcare Technologies
As the national healthcare landscape changes with the integration of the recent government laws and expansion of medical information technology, more emphasis has been placed on patient-centered care. I believe that if patient engagement were a drug, it would be the blockbuster drug of the century. Mobile healthcare technologies, a …
Read More »Nimble EMR
ClearPractice LLC iOS/Free Nimble is a full featured EMR designed specifically for the iPad and iOS platform. It provides busy doctors with all the information and tools they need to provide optimal patient care, whether in the exam room, hospital room, or family room.
Read More »SGLT2 Inhibitors Special Editions, February 2014
Now that there is a second SGLT-2 inhibitor on the market, prescribers will be approached even more often with information on this new class of drugs. These medications are likely to be big competitors with the DPP-4 inhibitors because they are similarly priced and have almost the same place in …
Read More »SGLT2 Inhibitors for Treatment of Type 2 Diabetes
In this special Homerun Slides presentation, details of the CANTATA-D2 study are reviewed comparing the effects and benefits of the SGLT2 inhibitors and DPP-4 inhibitors…. To download in PowerPoint (.ppt) format: SGLT2 Inhibitors for Treatment of Type 2 Diabetes See more SGLT-2 Resources
Read More »Editor’s Note, DCMS #176: Setting Targets Too High
Most of us who treat diabetes patients know that the hardest part is getting patients to make positive changes. We often set the targets so high that patients just give up. If you take a careful look at our Homerun Slides from Dr. Stanley Schwartz, you will see how small …
Read More »Obesity 2014, Part 3
In this week’s Homerun Slides, we discuss the Health Benefits of Modest Weight Loss; review some of the causes of the modern obesity crisis; and go over some of the Medical Consequences of Obesity….
Read More »Joslin’s Diabetes Deskbook, Updated 2nd Ed., Excerpt #41: Multiple Treatments for a Multicomponent Condition, Part 3
Richard S. Beaser, MD This week’s excerpt covers the following questions: Which routine laboratory tests are recommended for type 2 diabetes patients? Which goals need to be established? Why should the word "diet" not be used to treat your type 2 patients? Should the primary focus be on weight loss? …
Read More »Exercise Log from dLife
Exercise Log from dLife Print out copies of this simple daily exercise log from dLife and start charting your patients’ progress to help them set fitness goals. Exercise Log from dLife
Read More »AliveCor® an EKG on Your Smart Phone
AliveCor® an EKG on Your Smart Phone With the AliveCor System you can offer cardiac expertise to more of your patients, expanding the scope of your practice and providing valuable information about your patients’ cardiac health. The FDA has granted the company over-the-counter clearance for the AliveCor Heart Monitor, a …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.